| Nurses’ Time Allocation and Multitasking of Nursing Activities: A Time Motion Study PY Yen, M Kellye, M Lopetegui, A Saha, J Loversidge, EM Chipps, ... AMIA Annual Symposium Proceedings 2018, 1137, 2018 | 140 | 2018 |
| Spatial habitats from multiparametric MR imaging are associated with signaling pathway activities and survival in glioblastoma K Dextraze, A Saha, D Kim, S Narang, M Lehrer, A Rao, S Narang, D Rao, ... Oncotarget 8 (68), 112992, 2017 | 28 | 2017 |
| DEMARCATE: Density-based magnetic resonance image clustering for assessing tumor heterogeneity in cancer A Saha, S Banerjee, S Kurtek, S Narang, J Lee, G Rao, J Martinez, ... NeuroImage: Clinical 12, 132-143, 2016 | 23 | 2016 |
| A geometric variational approach to Bayesian inference A Saha, K Bharath, S Kurtek Journal of the American Statistical Association 115 (530), 822-835, 2020 | 20 | 2020 |
| May Dietary Supplementation Augment Respiratory Burst in Wound-site Inflammatory Cells? A Das, R Dickerson, P Das Ghatak, G Gordillo, S Chaffee, A Saha, ... Antioxidants and Redox Signaling, 2017 | 17 | 2017 |
| Skin Transcriptome of Middle-Aged Women Supplemented With Natural Herbo-mineral Shilajit Shows Induction of Microvascular and Extracellular Matrix Mechanisms A Das, M S. El Masry, SC Gnyawali, S Ghatak, K Singh, R Stewart, ... Journal of the American College of Nutrition 38 (6), 526-536, 2019 | 16 | 2019 |
| A Phase I Study of an IDO-1 Inhibitor (LY3381916) as Monotherapy and in Combination With an Anti-PD-L1 Antibody (LY3300054) in Patients With Advanced Cancer N Kotecki, P Vuagnat, BH O’Neil, S Jalal, S Rottey, H Prenen, ... Journal of Immunotherapy 44 (7), 264-275, 2021 | 14 | 2021 |
| Surrogate end points for survival in patients with advanced hepatocellular carcinoma treated with immune checkpoint inhibitors AX Zhu, Y Lin, D Ferry, RC Widau, A Saha Immunotherapy 14 (16), 1341-1351, 2022 | 13 | 2022 |
| AMIA Annual Symposium Proceedings PY Yen, M Kellye, M Lopetegui, A Saha, J Loversidge, EM Chipps, ... | 10 | 2018 |
| Geometric sensitivity measures for Bayesian nonparametric density estimation models A Saha, S Kurtek Sankhya A 81, 104-143, 2019 | 4 | 2019 |
| Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2-advanced breast cancer: Final overall survival results of MONARCH 3 MP Goetz, M Toi, J Huober, J Sohn, O Trédan, IH Park, M Campone, ... Annals of Oncology, 2024 | 2 | 2024 |
| Meta-analysis of surrogate endpoints for survival in patients with unresectable hepatocellular carcinoma treated with immune checkpoint inhibitor-based regimens. AX Zhu, Y Lin, DR Ferry, RC Widau, A Saha Journal of Clinical Oncology 40 (4_suppl), 483-483, 2022 | 1 | 2022 |
| A Geometric Framework for Modeling and Inference using the Nonparametric Fisher–Rao metric A Saha The Ohio State University, 2019 | 1 | 2019 |
| Abstract GS01-12: MONARCH 3: Final overall survival results of abemaciclib plus a nonsteroidal aromatase inhibitor as first-line therapy for HR+, HER2-advanced breast cancer M Goetz, M Toi, J Huober, JH Sohn, O Trédan, I Park, M Campone, ... Cancer Research 84 (9_Supplement), GS01-12-GS01-12, 2024 | | 2024 |
Sebastian KurtekDepartment of Statistics, The Ohio State University在 stat.osu.edu 的电子邮件经过验证
